EarlySight (private company)
See something wrong or missing? Let us know
Offices:Lausanne
Business model:B2B
EarlySight develops a next generation of eye diseases diagnostic tool, combining hardware and software via a medical device that can observe the cells affected at early-stage of the most prevalent retinal diseases such as age-related- macular degeneration, glaucoma or diabetic retinopathy.
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 6.4M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom